AngioDynamics, Inc. reported consolidated Goodwill impairment for third quarter ended February 29, 2024. For the quarter, the company reported Goodwill impairment of $159,476,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.82 USD | +0.17% | -3.48% | -25.77% |
Apr. 08 | North American Morning Briefing : Inflation Data, -2- | DJ |
Apr. 05 | Oppenheimer Upgrades AngioDynamics to Outperform From Perform, $12 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.77% | 233M | |
-2.54% | 187B | |
-1.85% | 106B | |
-4.26% | 66.9B | |
+1.39% | 49.45B | |
+16.82% | 48B | |
+4.06% | 40.84B | |
+3.49% | 26.48B | |
+0.65% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- ANGO Stock
- News AngioDynamics, Inc.
- AngioDynamics, Inc. Reports Consolidated Goodwill Impairment for Third Quarter Ended February 29, 2024